Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Mar 14:14:1390760.
doi: 10.3389/fonc.2024.1390760. eCollection 2024.

Editorial: New strategies to overcome platinum resistance in ovarian cancer

Jian-Jun Wei  1 , Fabio Martinelli  2
Affiliations
Editorial

Editorial: New strategies to overcome platinum resistance in ovarian cancer

Jian-Jun Wei et al. Front Oncol. .
No abstract available

Keywords: cancer therapy; carboplatin resistance; drug development; editorial; ovarian cancer.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Comment on

  • Editorial on the Research Topic New strategies to overcome platinum resistance in ovarian cancer

Similar articles

See all similar articles

References

    1. Yang L, Xie HJ, Li YY, Wang X, Liu XX, Mai J. Molecular mechanisms of platinum−based chemotherapy resistance in ovarian cancer (Review). Oncol Rep. (2022) 47(4):82. doi: 10.3892/or - DOI - PMC - PubMed
    1. Ortiz M, Wabel E, Mitchell K, Horibata S. Mechanisms of chemotherapy resistance in ovarian cancer. Cancer Drug Resist. (2022) 5:304–16. doi: 10.20517/cdr - DOI - PMC - PubMed
    1. Wong-Brown MW, van der Westhuizen A, Bowden NA. Targeting DNA repair in ovarian cancer treatment resistance. Clin Oncol (R Coll Radiol). (2020) 32:518–26. doi: 10.1016/j.clon.2020.03.005 - DOI - PubMed
    1. Jurkovicova D, Neophytou CM, Gasparovic AC, Goncalves AC. DNA damage response in cancer therapy and resistance: challenges and opportunities. Int J Mol Sci. (2022) 23(23):14672. doi: 10.3390/ijms232314672 - DOI - PMC - PubMed
    1. Roberts CM, Cardenas C, Tedja R. The role of intra-tumoral heterogeneity and its clinical relevance in epithelial ovarian cancer recurrence and metastasis. Cancers (Basel). (2019) 11(8):1083. doi: 10.3390/cancers11081083 - DOI - PMC - PubMed

Publication types

LinkOut - more resources